With ongoing support and a focus on your individual needs, Klinic remains your trusted partner in pursuing health and wellness in Cincinnati
A recent Multicenter survey revealed that 40.2% of participating clinicians had never prescribed this drug class, with key barriers including high treatment costs, suboptimal patient adherence, safety concerns, and insufficient therapeutic knowledge [29]
Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk
Brown E, Wilding JPH, Barber TM, Alam U, Cuthbertson DJ
In a Phase II trial, retatrutide demonstrated a mean weight reduction of over 17.5% in adults without diabetes but with obesity or pre-obesity, marking a significant advancement in weight management therapies